#32 Pharmacovigilance in older adults – Giova...

Send a text message to the show!Medical device pharmacovigilance is complicated. Alongside clinical safety, there are technology risks, from cybersecurity threats to outdated software, that can put patients at risk. In this two-part episode, Omar Aimer, President of ISoP and form ...  Show more

Send a text message to the show!Medical device pharmacovigilance is complicated. Alongside clinical safety, there are technology risks, from cybersecurity threats to outdated software, that can leave patients vulnerable. In this two-part episode, Omar Aimer, president of ISoP and ...  Show more

View the Show Notes Page for This Episode

<a href= "https://peterattiamd.com/subscribe/?utm_source=podcast-feed ...

In this episode of our pharmacology podcast, we take a deep dive into the pharmacology of levomilnacipran (Fetzima), a unique serotonin-norepinephrine reuptake inhibitor (SNRI) approved for the treatment of major depressive disorder (MDD) in adults. Designed for pharmacy students ...  Show more

In 2021 Dr. Kiran Rabheru, a professor of psychiatry at the University of Ottawa and a geriatric psychiatrist, found himself at the center of a medical debate. The World Health Organization wanted to officially designate “old age” as a disease, but with more than 40 years of work ...  Show more

In this episode of the PTJ Podcast, Editor-in-Chief Steven George, PT, PhD, FAPTA, talks with Alexander Garbin, PT, DPT, PhD, and Jennifer Stevens-Lapsley, PT, PhD, FAPTA, about their recently published companion papers, which evaluated the effectiveness of a progressive multi ...